Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 21:31:56 GMT 2025
by
admin
on
Mon Mar 31 21:31:56 GMT 2025
|
| Protein Sub Type | |
| Sequence Type | COMPLETE |
| Record UNII |
I8309403R0
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
L03AB13
Created by
admin on Mon Mar 31 21:31:56 GMT 2025 , Edited by admin on Mon Mar 31 21:31:56 GMT 2025
|
||
|
EMA ASSESSMENT REPORTS |
PLEGRIDY (AUTHORIZED: MULTIPLE SCLEROSIS)
Created by
admin on Mon Mar 31 21:31:56 GMT 2025 , Edited by admin on Mon Mar 31 21:31:56 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2108677
Created by
admin on Mon Mar 31 21:31:56 GMT 2025 , Edited by admin on Mon Mar 31 21:31:56 GMT 2025
|
PRIMARY | |||
|
1211327-92-2
Created by
admin on Mon Mar 31 21:31:56 GMT 2025 , Edited by admin on Mon Mar 31 21:31:56 GMT 2025
|
PRIMARY | |||
|
I8309403R0
Created by
admin on Mon Mar 31 21:31:56 GMT 2025 , Edited by admin on Mon Mar 31 21:31:56 GMT 2025
|
PRIMARY | |||
|
C170298
Created by
admin on Mon Mar 31 21:31:56 GMT 2025 , Edited by admin on Mon Mar 31 21:31:56 GMT 2025
|
PRIMARY | |||
|
DB09122
Created by
admin on Mon Mar 31 21:31:56 GMT 2025 , Edited by admin on Mon Mar 31 21:31:56 GMT 2025
|
PRIMARY | |||
|
SUB121165
Created by
admin on Mon Mar 31 21:31:56 GMT 2025 , Edited by admin on Mon Mar 31 21:31:56 GMT 2025
|
PRIMARY | |||
|
7637
Created by
admin on Mon Mar 31 21:31:56 GMT 2025 , Edited by admin on Mon Mar 31 21:31:56 GMT 2025
|
PRIMARY | |||
|
9661
Created by
admin on Mon Mar 31 21:31:56 GMT 2025 , Edited by admin on Mon Mar 31 21:31:56 GMT 2025
|
PRIMARY | |||
|
Peginterferon Beta
Created by
admin on Mon Mar 31 21:31:56 GMT 2025 , Edited by admin on Mon Mar 31 21:31:56 GMT 2025
|
PRIMARY | |||
|
100000144525
Created by
admin on Mon Mar 31 21:31:56 GMT 2025 , Edited by admin on Mon Mar 31 21:31:56 GMT 2025
|
PRIMARY | |||
|
1546168
Created by
admin on Mon Mar 31 21:31:56 GMT 2025 , Edited by admin on Mon Mar 31 21:31:56 GMT 2025
|
PRIMARY | RxNorm | ||
|
YY-79
Created by
admin on Mon Mar 31 21:31:56 GMT 2025 , Edited by admin on Mon Mar 31 21:31:56 GMT 2025
|
PRIMARY | |||
|
5137
Created by
admin on Mon Mar 31 21:31:56 GMT 2025 , Edited by admin on Mon Mar 31 21:31:56 GMT 2025
|
PRIMARY | |||
|
Peginterferon beta-1a
Created by
admin on Mon Mar 31 21:31:56 GMT 2025 , Edited by admin on Mon Mar 31 21:31:56 GMT 2025
|
PRIMARY | |||
|
I8309403R0
Created by
admin on Mon Mar 31 21:31:56 GMT 2025 , Edited by admin on Mon Mar 31 21:31:56 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_31 | 1_141 |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_80 |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| FRAGMENT | [1_1] | METHIONINE |
Amount:
|
N-((METHYL-POLYETHYLENE GLYCOL 24000)-2(RS)-2-METHYL-PROPYL)METHIONINE | 0S50T20EU0 | |
| FRAGMENT | [1_119] | SERINE |
Amount:
|
DEXFOSFOSERINE | VI4F0K069V |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT(NOT DESCRIBED) | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|